Alterity Therapeutics Limited (ASX:ATH) Directors Insider Transactions



The Directors and Chief Executives of Alterity Therapeutics Limited (ASX:ATH) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Alterity Therapeutics Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Alterity Therapeutics Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Alterity Therapeutics Limited Directors/Insider Transactions Activity

List of Insider trades activity from Alterity Therapeutics Limited (ATH).

DateDirectorDirector's TitleSharesValueNote
08 Apr 2019Mihaly (George William)Former226,666--
30 Jun 2018Angus (Dianne)Former146,128--
01 Jun 2015Kempler (Geoffrey Paul)Chief Executive Officer200,00038,440Purchase at price 0.19 per share.
30 Jun 2014Angus (Dianne)Chief Operating Officer46,128--
01 May 2012Kempler (Geoffrey Paul)Chairman of the Board156,00025,958Purchase at price 0.17 per share.
04 Jan 2012Kempler (Geoffrey Paul)Chairman of the Board600,000108,360Purchase at price 0.18 per share.
30 Jun 2011Angus (Dianne)Chief Operating Officer150,000--
04 Jan 2011Marks (Paul)Former8,589,361--
30 Jun 2008Angus (Dianne)Chief Operating Officer250,000--
30 Jun 2008Meltzer (Brian Derek)Director (Independent)167,817--